New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
Frati F, Cecchi L, Scala E, Ridolo E, Dell’Albani I, Makrì E, Pajno GB, Incorvaia C. Biologics: Targets and Therapy. 2014;8:221–226.On page 223, Figure 1 should be replaced with the revised version as shown below:On page 224, line 4 in the left column, "many&a...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e08611437a334897a46acc787d6961de |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e08611437a334897a46acc787d6961de |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e08611437a334897a46acc787d6961de2021-12-02T07:23:30ZNew product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]1177-5491https://doaj.org/article/e08611437a334897a46acc787d6961de2015-06-01T00:00:00Zhttp://www.dovepress.com/corrigendum-new-product-development-with-the-innovative-biomolecu-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Frati F, Cecchi L, Scala E, Ridolo E, Dell’Albani I, Makrì E, Pajno GB, Incorvaia C. Biologics: Targets and Therapy. 2014;8:221–226.On page 223, Figure 1 should be replaced with the revised version as shown below:On page 224, line 4 in the left column, "many" should be replaced with "all".On page 224, line 7 in the left column, "but only the major allergen Phl p 5 is measured in μg" should be replaced with "such as group 1 and group 5 allergens (Figure1, Table 2)".On page 224, line 9 in the left column, the reference to "(Figure 1)" should be removed.Read the original articleFrati FCecchi LScala ERidolo EDell'Albani IMakrì EPajno GBIncorvaia CDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2015, Iss default, Pp 45-46 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Frati F Cecchi L Scala E Ridolo E Dell'Albani I Makrì E Pajno GB Incorvaia C New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
| description |
Frati F, Cecchi L, Scala E, Ridolo E, Dell’Albani I, Makrì E, Pajno GB, Incorvaia C. Biologics: Targets and Therapy. 2014;8:221–226.On page 223, Figure 1 should be replaced with the revised version as shown below:On page 224, line 4 in the left column, "many" should be replaced with "all".On page 224, line 7 in the left column, "but only the major allergen Phl p 5 is measured in μg" should be replaced with "such as group 1 and group 5 allergens (Figure1, Table 2)".On page 224, line 9 in the left column, the reference to "(Figure 1)" should be removed.Read the original article |
| format |
article |
| author |
Frati F Cecchi L Scala E Ridolo E Dell'Albani I Makrì E Pajno GB Incorvaia C |
| author_facet |
Frati F Cecchi L Scala E Ridolo E Dell'Albani I Makrì E Pajno GB Incorvaia C |
| author_sort |
Frati F |
| title |
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
| title_short |
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
| title_full |
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
| title_fullStr |
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
| title_full_unstemmed |
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
| title_sort |
new product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [corrigendum] |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/e08611437a334897a46acc787d6961de |
| work_keys_str_mv |
AT fratif newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT cecchil newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT scalae newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT ridoloe newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT dell39albanii newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT makrigravee newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT pajnogb newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum AT incorvaiac newproductdevelopmentwiththeinnovativebiomolecularsublingualimmunotherapyformulationsforthemanagementofallergicrhinitiscorrigendum |
| _version_ |
1718399488145489920 |